Extension Study to Evaluate the Post-Treatment Safety and Duration of Clinical Effect of LIPO-202

Summary

LIPO-202-CL-23 is a follow-on study to evaluate the post-treatment safety and duration of clinical effect of LIPO-202 in subjects that completed either the LIPO-202-CL-18 (NCT02397499) or LIPO-202-CL-19 (NCT02398188). No risks related to treatment are anticipated as subjects will not receive additional treatment with LIPO-202 or Placebo for LIPO-202 in this follow-on study.

Timeline

Start

2015-06

Primary completion

2015-12-23

Completion

2016-02-26

Drugs

Indications